Co-Authored by Dr. Frank Cammisa and Dr. Alexander Hughes
Spine surgeons have always known the lumbar disc nucleus has a short temper — but now, thanks to a New York–Tokyo collaboration, we know a little more about what really pushes it over the edge.
A team from Hospital for Special Surgery (HSS), working with Showa University in Tokyo, has unveiled new intel on what drives progression of nucleus pulposus degeneration. Their retrospective study, “Risk factors for progression of nucleus pulposus degeneration in the lumbar intervertebral disc,” just dropped in the July 2025 Spine Journal, and the findings point to two culprits: age and congestive heart failure.
Yes, you read that right. Alongside the usual “time and gravity” suspects, heart failure is now on the risk-factor list.
From Subjective Grades to Cold, Hard Numbers
Forget the Pfirrmann grade’s “squint-and-guess” approach. The HSS/Showa team went quantitative with the Disc Signal Index Intensity (DSI²) — an objective imaging biomarker that turns MRI data into a continuous value between 0 and 1, reflecting the disc’s degeneration stage with high inter- and intra-reader reliability.
How? By indexing the disc’s MRI signal intensity to cerebrospinal fluid. No more five vague categories. No more “I think it’s a 3, maybe a 4 if I’ve had my coffee.” Just precise, reproducible numbers.
As co-author Frank Cammisa Jr., M.D., Chief Emeritus of HSS Spine, put it: “MRI is not typically a quantification tool. The DSI² changes that. It’s discreet, reproducible, and far more sensitive to subtle changes than legacy grading.”
Co-author Alexander Hughes, M.D., a spine surgeon at HSS, said, “The Disc Signal Index Intensity leads to increased fidelity in understanding degenerative disc disease (DDD) status and progression. This is already leading to new understandings regarding the natural history of degenerative disc disease and insights into possibly modifiable risk factors and therapies.”
The Study
Researchers analyzed 1,439 discs in 325 patients over time. The verdict: older patients and those with congestive heart failure had higher odds of progression in disc nucleus degeneration. The practical payoff? Earlier identification of patients at risk for degenerative lumbar conditions — and maybe, just maybe, a window to slow the slide.
Co-author Hughes sees it as a game-changer: “The DSI² is robust, reproducible, and captures the full spectrum of degeneration. This is already leading to new insights into the natural history of disc disease — and potential modifiable risk factors.”
Why This Matters
This isn’t just another tweak in how we look at discs. It’s part of a broader push to extract quantitative biomarkers across the spine and musculoskeletal system — mapping the architecture of spinal stability and opening doors to more targeted interventions.
For spine surgeons, that means moving past subjective gradations toward a future where your MRI readouts aren’t just “looks worse than last year,” but “degenerated by 0.08 on the DSI² scale” — with the data to guide both timing and type of intervention.
In The Media
SpineCare of NY has been highlighted in the media for our innovative spine care and outstanding results. Explore our features here.
Forms
Download all necessary patient forms to prepare for your SpineCare of NY appointment.
